Related Experiment Video
Updated: Jan 26, 2026

A Modified Technique for Arteriovenous Fistula Construction in Rabbits
Published on: February 10, 2023
Coronary arteriovenous fistula in pediatric patients: a 17-year institutional experience
Nan-Koong Wang1, Li-Yin Hsieh, Ching-Tsuen Shen
1Department of Pediatrics, Cathay General Hospital, 280 Jen-Ai Road, Section 4, Taipei, Taiwan.
Insights
Pediatric coronary arteriovenous fistula (CAVF) often presents with symptoms, and surgical closure alone may not resolve fistula size. Long-term monitoring is crucial for managing potential complications like recanalization and thrombus formation.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Vascular Surgery
Background:
- Coronary arteriovenous fistula (CAVF) is a rare congenital anomaly in children.
- Clinical presentations and long-term outcomes of pediatric CAVF are not fully understood.
Purpose of the Study:
- To investigate the natural history and long-term outcomes of pediatric patients with CAVF.
- To analyze treatment strategies and complications over a 17-year period.
Main Methods:
- Retrospective review of medical records of 10 pediatric patients with CAVF.
- Data collection included clinical presentation, diagnostic imaging (echocardiography, catheterization, angiography), and surgical outcomes.
Main Results:
- CAVF diagnosed via echocardiography or cardiac catheterization/angiography.
- Congestive heart failure, myocardial ischemia, and infarction were observed in some patients.
- Postoperative complications included persistent dilation, recanalization, thrombus formation, calcification, and ventricular aneurysm.
Conclusions:
- Pediatric CAVF patients are typically symptomatic, unlike adults.
- Surgical ligation alone does not consistently reduce fistula size.
- Long-term follow-up is essential to monitor for complications; antiplatelet therapy is recommended for specific cases.
Background And Purpose:
Coronary arteriovenous fistula (CAVF) is a rare congenital anomaly in pediatric patients. Its clinical manifestations vary considerably and its long-term outcome is not fully understood. This study sought to determine the natural history and long-term outcome in CAVF patients treated over a 17-year period at Cathay General Hospital in Taipei.
Materials And Methods:
The medical records of all 10 pediatric patients (five boys and five girls aged between 15 days and 15 years) with CAVF treated from 1983 through 2000 at our hospital were reviewed. Data collected included symptoms and signs, the findings of electrocardiography, echocardiography, catheterization, and angiography, and surgical results.
Results:
CAVF was diagnosed on the basis of color Doppler echocardiography in eight patients and by cardiac catheterization and angiography in two. Congestive heart failure was found in four patients and both myocardial ischemia and infarction were found in two patients. Most of the affected coronary arteries were tortuous and dilated with a mean diameter of 12.6 mm (range 5-40 mm). Under cardiopulmonary bypass, fistulous terminations were sutured in seven patients, three of whom were found to have multiple fistulous openings. Postoperative follow-up examinations revealed that all of the affected coronary arteries and fistulas remained dilated and tortuous, except in one patient. Two patients who had distal CAVF developed coronary thrombus, calcification, and ventricular aneurysm at 2 and 10 years after operation, respectively. Another patient developed fistulous recanalization 7 years after operation, but this abnormal channel had disappeared again 3 years after recanalization. One patient developed an iatrogenic CAVF 8 years after surgical repair of tetralogy of Fallot.
Conclusions:
Unlike adults, pediatric patients with CAVF tend to be symptomatic. Ligation of the fistulous termination alone does not reduce the size of the fistula. Our findings indicate that long-term follow-up is essential due to the possibility of postoperative recanalization, persistent dilation of the coronary artery and ostium, thrombus formation, calcification, and myocardial infarction. In addition, postoperative antiplatelet therapy is recommended, especially in patients with distal CAVF and abnormally dilated coronary arteries.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
What is an Experiment?

